Anne van Rongen

1.9k citations

21 papers · 1.4k indexed · 1 hit paper · h-index 17

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 6
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 6
Radiological and Ultrasound Technology top 5%
General Health Professions top 5%
- Workplace Health and Well-being 7
- Employment and Welfare Studies 3
Anesthesiology and Pain Medicine top 5%
Pediatrics, Perinatology and Child Health
- Pharmaceutical studies and practices 5
Oncology
- Drug Transport and Resistance Mechanisms 3
Physiology
- Diet and metabolism studies 3
Applied Psychology
- Behavioral Health and Interventions 3
Speech and Hearing
- School Health and Nursing Education 2

Co-authors: Alex Burdorf Suzan JW Robroek Catherijne A. J. Knibbe Frank J. van Lenthe Margreke J. E. Brill Jeroen Diepstraten John N. van den Anker Simone van Kralingen
Cited by: Pharmacology Radiological and Ultrasound Technology
Journals: PLoS ONE (1 paper)The Annual Review of Pharmacology and Toxicology (1 paper)American Journal of Preventive Medicine (1 paper)
Partner nations: Netherlands United States Switzerland

In The Last Decade

Anne van Rongen

21 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Anne van Rongen

Since Specialization

Citations

This map shows the geographic impact of Anne van Rongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne van Rongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne van Rongen more than expected).

Fields of papers citing papers by Anne van Rongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne van Rongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne van Rongen. The network helps show where Anne van Rongen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anne van Rongen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne van Rongen Line = papers co-authored together Anne van Rongen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing? Clinical Pharmacokinetics ·Jeroen Diepstraten,Anne van Rongen,Marianne P. Zijlstra,Marieke J. H. A. Kruip,Pim L. J. van der Heiden,Rob ter Heine	2022	1
2	An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables Expert Opinion on Drug Metabolism & Toxicology ·Anne van Rongen,Elke H. J. Krekels,Elisa A. M. Calvier,Saskia N. de Wildt,An Vermeulen,Catherijne A. J. Knibbe	2022	16
3	Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial Pediatric Drugs ·Anne van Rongen,Marloes P. van der Aa,Maja Matić,Ron H. N. van Schaik,Vera H.M. Deneer,Marja MJ van der Vorst,Catherijne A. J. Knibbe	2018	24
4	Exposure to acetaminophen and all its metabolites upon 10, 15, and 20 mg/kg intravenous acetaminophen in very-preterm infants Pediatric Research ·Robert B. Flint,Daniëlla Roofthooft,Anne van Rongen,Richard A. van Lingen,Johannes N. van den Anker,Monique van Dijk,Karel Allegaert,Dick Tibboel,Catherijne A. J. Knibbe,Sinno H. P. Simons	2017	31
5	Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults Clinical Pharmacokinetics ·Anne van Rongen,Margreke J. E. Brill,Janelle D. Vaughns,Pyry A. J. Välitalo,Eric P.A. van Dongen,Bert van Ramshorst,Jeffrey S. Barrett,Johannes N. van den Anker,Catherijne A. J. Knibbe	2017	22
6	Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen Clinical Pharmacokinetics ·Anne van Rongen,Pyry A. J. Välitalo,Mariska Y. M. Peeters,Djamila Boerma,Fokko W. Huisman,Bert van Ramshorst,Eric P.A. van Dongen,Johannes N. van den Anker,Catherijne A. J. Knibbe	2016	80
7	Does Weight Impact Anidulafungin Pharmacokinetics? Clinical Pharmacokinetics ·Vincent J. Lempers,Anne van Rongen,Eric P. van Dongen,Bert van Ramshorst,David M. Burger,Rob E. Aarnoutse,Catherijne A. J. Knibbe,Roger J. M. Brüggemann	2016	19
8	Educational Inequalities in Exit from Paid Employment among Dutch Workers: The Influence of Health, Lifestyle and Work PLoS ONE ·Suzan JW Robroek,Anne van Rongen,Coos H. Arts,Ferdy W. H. Otten,Alex Burdorf,Merel Schuring	2015	75
9	The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery Pharmaceutical Research ·Margreke J. E. Brill,Anne van Rongen,Eric P. van Dongen,Bert van Ramshorst,Eric J. Hazebroek,Adam S. Darwich,Amin Rostami‐Hodjegan,Catherijne A. J. Knibbe	2015	54
10	Population Pharmacokinetic Model Characterizing 24‐Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers CPT Pharmacometrics & Systems Pharmacology ·Anne van Rongen,Laura Kervezee,MJE Brill,Hélène van Meir,Jan den Hartigh,Henk‐Jan Guchelaar,Johanna H. Meijer,Jacobus Burggraaf,Floor van Oosterhout	2015	22
11	Sustainable Employability & Participation in Health Promotion Programs Anne van Rongen	2015	1
12	Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents British Journal of Clinical Pharmacology ·Anne van Rongen,Janelle D. Vaughns,Ganesh S. Moorthy,Jeffrey S. Barrett,Catherijne A. J. Knibbe,Johannes N. van den Anker	2015	37
13	The Contribution of Work Engagement to Self-Perceived Health, Work Ability, and Sickness Absence Beyond Health Behaviors and Work-Related Factors Journal of Occupational and Environmental Medicine ·Anne van Rongen,Suzan JW Robroek,Wilmar B. Schaufeli,Alex Burdorf	2014	67
14	How needs and preferences of employees influence participation in health promotion programs: a six-month follow-up study BMC Public Health ·Anne van Rongen,Suzan JW Robroek,Wouter van Ginkel,Dennis Lindeboom,Martin Pet,Alex Burdorf	2014	23
15	Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers Clinical Pharmacokinetics ·Margreke J. E. Brill,Anne van Rongen,Aletta P. I. Houwink,Jacobus Burggraaf,Bert van Ramshorst,René J. Wiezer,Eric P.A. van Dongen,Catherijne A. J. Knibbe	2014	73
16	Barriers and facilitators for participation in health promotion programs among employees: a six-month follow-up study BMC Public Health ·Anne van Rongen,Suzan JW Robroek,Wouter van Ginkel,Dennis Lindeboom,Bibiëlle Altink,Alex Burdorf	2014	60
17	The importance of internal health beliefs for employees' participation in health promotion programs Preventive Medicine ·Anne van Rongen,Suzan JW Robroek,Alex Burdorf	2014	16
18	Workplace Health Promotionbreakdown → American Journal of Preventive Medicine ·Anne van Rongen,Suzan JW Robroek,Frank J. van Lenthe,Alex Burdorf	2013	352
19	Influence of work-related characteristics and work ability on changing employer or leaving the profession among nursing staff Journal of Nursing Management ·Anne van Rongen,Suzan JW Robroek,B.I.J.M. van der Heijden,Roel Schouteten,Hans Martin Hasselhorn,Alex Burdorf	2013	23
20	Impact of Obesity on Drug Metabolism and Elimination in Adults and Children Clinical Pharmacokinetics ·Margreke J. E. Brill,Jeroen Diepstraten,Anne van Rongen,Simone van Kralingen,John N. van den Anker,Catherijne A. J. Knibbe	2012	286

About Anne van Rongen

Anne van Rongen is a scholar working on Pharmacology, Applied Psychology and Nephrology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Workplace Health and Well-being (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Employment and Welfare Studies (3 papers), Diet and metabolism studies (3 papers), Behavioral Health and Interventions (3 papers) and School Health and Nursing Education (2 papers). The work is most often cited by research in Pharmacology (187 citations), Pharmacology (317 citations) and Radiological and Ultrasound Technology (92 citations). Anne van Rongen has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Alex Burdorf, Suzan JW Robroek, Catherijne A. J. Knibbe, Frank J. van Lenthe, Margreke J. E. Brill, Jeroen Diepstraten, John N. van den Anker, Simone van Kralingen, Bert van Ramshorst and Johannes N. van den Anker. Their work appears in journals such as PLoS ONE, The Annual Review of Pharmacology and Toxicology and American Journal of Preventive Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact